How we can help?
Medical Devices and Technologies
Aranca provides actionable intelligence and advisory to medical technology companies on products, innovation and growth areas, collaboration opportunities, and business planning to aid decision making
Medical Devices and Technologies
Aranca provides actionable intelligence and advisory to medical technology companies on products, innovation and growth areas, collaboration opportunities, and business planning to aid decision making
perspectives
THOUGHT LEADERSHIP
Our Pharma team actively contributes with expert opinions and insights on the Pharma sector, covering a broad range of topics including sector outlook, new trends and their impact, opportunities in the sector and industry best practices.
Featured case studies
Go-to-Market for an Asian food & nutrition company to expand into liver disease medical foods in the US
Our Approach
- Review of scientific literature; sourcing of industry information
- 15+ interviews with healthcare professionals to assess the demand dynamics
- 20+ interviews with competitors to benchmark capabilities and strategies
- Roadmap to build commercial capabilities for market entry
IMPACT
Our fact-based analysis and recommendations enabled the Client to develop a marketing plan & open negotiations with key partners in pursuit of building their commercial capabilities in the US.
Unmet Need Assessment for a rare autoimmune indication
Our Approach
- Assessment of the disease epidemiology and treatment landscape
- In depth analysis of the patient segmentation and patient journey
- Competitive assessment of the pipeline as well as the marketed therapies
- Key stakeholder assessment to identify the unmet needs
IMPACT
Our findings enabled the Client to develop an in depth understanding of the rare disease and identify key unmet needs in the market
Evaluation of clinical trials for drugs used in selected immune – dermatological indications
Our Approach
- Evaluation of clinical pipeline of the indications
- Evaluation of the trial design and the results of the key clinical endpoints
- Insights on success factors and reasons for trial failures
- Overview of the treatment guidelines, standard of care and unmet need
IMPACT
Our findings enabled the Client to develop the clinical trial protocol for their early stage asset and helped them to do a inter asset and intra asset comparison of key clinical endpoints of the drugs
Market assessment of Efavirenz (EFV) API in India for a leading European specialty chemicals supplier
Our Approach
- Discussions with heads of various API manufacturers and WHO executives
- Analyzed production and trade data to ascertain market dynamics
- Reviewed regulatory policies and their impact on demand
- Assessed plans of major pharma companies to estimate future demand
IMPACT
Our analysis helped the Client to understand evolving market trends; additionally, the fact-based insights enabled them to strategically position themselves to supply DEZ used in synthesis of EFV.
Vaccine Schedules & Concomitancy Research in Dengue Endemic Markets for a Japanese pharma company
Our Approach
- Identified the type of vaccines and coverage by specified age group
- Segregated data for expanded program on immunization & private market
- Estimated potential demand across the age groups in the private market
- Assessed market share of leading players in the private market
IMPACT
Our analysis of leading vaccines in the pre-specified age segments for the private market enabled the Client to identify potential markets for their future dengue vaccine.
Market and competitor intelligence on Systemic Lupus Erythematosus in the US, EU, and Japanese markets
Our Approach
- Patient ecosystem analysis covering incidence, prevalence, disease burden
- Analyzed marketed drugs, drug failures and reasons for failure
- Drug pipeline overview covering alias/brand name, dosages & key claims
- Also, mechanism of action and route of administration were analyzed
IMPACT
Our research provided the client with insights on competitors products, strategies and plans, and enabled them to design clinical trial end points for their drug
CLIENT TESTIMONIALS
Talk To Us
We will connect you to the right professional within our Healthcare Research & Advisory Team